Company Filing History:
Years Active: 2020
Title: Jason Ellsworth - Innovator in Hyperthermia Technology
Introduction
Jason Ellsworth is a notable inventor based in Farmington, UT (US). He has made significant contributions to the field of medical technology, particularly in the area of hyperthermia treatment for brain tissues. His innovative approach has the potential to enhance therapeutic outcomes for patients.
Latest Patents
Ellsworth holds a patent for an "Apparatus and method for creating small focus deep hyperthermia in tissues of the brain." This invention features a radio frequency annular phased array hyperthermia system that provides a heated focal zone with a diameter of 3 cm or less in a tissue mass. The system includes at least 42 radio frequency energy applicators arranged in three rings, designed to surround the tissue mass. A bolus with a dielectric constant is positioned between the energy applicators and the tissue mass. The applicators operate at a frequency of at least about 900 MHz to create the heated focal zone. The design ensures that the circumferential spacing between adjacent applicators in each ring, as well as the spacing between adjacent side-by-side rings, is less than a critical distance, which is interdependent on various factors including the frequency of the energy radiated and the size of the tissue mass.
Career Highlights
Ellsworth's career is marked by his dedication to advancing medical technology. His work at Pyrexar Medical Inc. has allowed him to focus on developing innovative solutions that address complex medical challenges. His patent reflects his commitment to improving patient care through technology.
Collaborations
Ellsworth collaborates with talented professionals in his field, including his coworker Paul F Turner. Together, they work towards enhancing the capabilities of hyperthermia treatments and exploring new avenues for medical advancements.
Conclusion
Jason Ellsworth is a pioneering inventor whose work in hyperthermia technology is making a significant impact in the medical field. His innovative patent demonstrates his commitment to improving treatment options for patients with brain tissue concerns.